Promoter polymorphisms of cysteinyl leukotriene type 1 receptor in patients with severe asthma Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology Year: 2007
Expression of cysteinyl leukotriene type 1 receptor splice variants in asthmatic patients with different promoter genotypes Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
Leukotriene C4 synthase polymorphism does not associate with clinical response to leukotriene receptor antagonists in persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 303s Year: 2002
Alternative transcripts of cysteinyl leukotriene receptor 1 in patients with bronchial asthma Source: Annual Congress 2007 - Novel mediators of cellular pathology Year: 2007
Homozygosity for the FCER2 gene is associated with an increased use of leukotriene receptor antagonists Source: International Congress 2017 – Insight into childhood asthma and paediatric pulmonology Year: 2017
An association study between thromboxane A2 receptor gene T924C polymorphism and the severity of asthma in Chinese children Source: Eur Respir J 2001; 18: Suppl. 33, 451s Year: 2001
Genetic association studies of interleukin-13 receptor α1 subunit gene polymorphisms in asthma and atopy Source: Eur Respir J 2007; 30: 40-47 Year: 2007
The CysLT1 receptor antagonist montelukast inhibits mast cell activation induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2016 – Clinical and molecular studies in asthma Year: 2016
Association of polymorphisms in interleukin-13 receptor pathway genes with atopy and lung function in asthmatics Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008
Interaction between the Arg16 homozygous genotype, inhaled corticosteroids and long acting beta agonists for asthma exacerbations in children? Leukotriene receptor antagonists to the rescue? Source: Annual Congress 2013 –Asthma and lung development: from genes to environment Year: 2013
A common intragenic marker of cysteinyl leukotrienes receptor-1 (T927C) does not correlate with a clinical response to the receptor's antagonist but is associated with peripheral blood eosinophilia Source: Eur Respir J 2001; 18: Suppl. 33, 260s Year: 2001
Increased expression of the cysteinil leukotriene 1 receptor (CysLT1-R) in the bronchial epithelium of smokers Source: Eur Respir J 2001; 18: Suppl. 33, 74s Year: 2001
The CysLT1 receptor antagonist montelukast blocks bronchoconstriction induced by inhaled leukotriene E4 in subjects with asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015
Polymorphisms of the glucocorticoid receptor gene and bronchial asthma in children Source: Annual Congress 2008 - Risk factors for childhood asthma and allergy Year: 2008
Arg16Gly polymorphism of the β2 -adrenergic receptor gene does not modulate clinical response to salmeterol in subjects with asthmaSource: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment Year: 2008
Clustering of patients with bronchial asthma with regard to the genotypes for Bcl1 polymorphism in the glucocorticoid receptor gene Source: International Congress 2017 – Gene signatures in bronchial diseases Year: 2017
The effects of a cysteinyl leukotriene receptor antagonist, pranlukast, on dendritic cell chemoattractants in the airways of subjects with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 132s Year: 2004
Association of genetic variations of CC chemokine receptor-2 (CCR2) with atopic asthma, but not with nonatopic asthma Source: Annual Congress 2005 - Genetic polymorphisms and molecular mechanisms in asthma pathophysiology Year: 2005
Analysis of glucocorticoid receptor gene polymorphisms in asthmatic children Source: Eur Respir J 2007; 30: Suppl. 51, 710s Year: 2007
Expression of the cysteinyl leukotriene receptors cysLT1 and cysLT2 in the airway structural cells Source: Eur Respir J 2005; 26: Suppl. 49, 346s Year: 2005